get a key
steadybase-$ company AURA
account_id none on file
legal_name Aura Biosciences, Inc.
ticker AURA
cik 1501796
domain aurabiosciences.com
entry_point_account_id none on file
name Aura Biosciences Inc.
exchange Nasdaq
sector Health Care
hq Boston, MA, United States
calls 0 filings 6 executives 2 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include professional fees for legal, accounting, auditing, tax and consulting services; travel expenses; and facility-related expenses, which include allocated expenses for rent and maintenance of facilities and other operating costs not included in research and development.

filing / Aug 11, 2026 / receipt

In August 2026, our Board of Directors approved a plan to streamline our operating plan and organizational structure to focus resources in ocular oncology, including a reduction in force of approximately 20% of our workforce.

filing / Aug 11, 2026 / receipt

Moreover, in August 2026, we approved a plan to streamline our operating plan and organizational structure to focus resources in ocular oncology, including a reduction in force of approximately 20% of our workforce.

filing / Aug 11, 2026 / receipt

The increased costs may require us to reduce costs in other areas of our business or increase the prices of our products once commercialized.

filing / Aug 11, 2026 / receipt

healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications.

filing / Aug 11, 2026 / receipt

Further, as a result of increased hybrid work, a significant number of our employees and partners are working remotely, which increases the risk of a cybersecurity incident or data breach or other data and cybersecurity issues.

filing / Aug 11, 2026 / receipt

executives
Anthony Gibney Chief Financial and Business Officer linkedin receipt
Natalie Holles Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2026-05-04 Chief Executive Officer, appointed sec_8k
2025-05-15 Chief Financial and Business Officer, appointed sec_8k
mcp_package_hint
steadybase-$